Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02393794
Title Romidepsin Plus Cisplatin in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
Recruitment Suspended
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Priyanka Sharma
Indications

breast cancer

triple-receptor negative breast cancer

Therapies

Cisplatin + Nivolumab + Romidepsin

Cisplatin + Romidepsin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Kansas Cancer Center - Clinical Research Center Fairway Kansas 66205 United States Details
University of Kansas Cancer Center - West Kansas City Kansas 66112 United States Details
University of Kansas Cancer Center - Overland Park Overland Park Kansas 66210 United States Details
University of Kansas Cancer Center - Westwood Westwood Kansas 66205 United States Details
University of Kansas Cancer Center - South Kansas City Missouri 64131 United States Details
University of Kansas Cancer Center - North Kansas City Missouri 64154 United States Details
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field